Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Essential Thrombocythemia

Clinical Trial at: Texas Oncology - Wichita Falls

Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy (MOST) (INCB-MA-MF-401)

  • Details

ClinicalTrials.gov ID: NCT02953704
Diagnosis Type: High Risk
USOR Number: 16092

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Hematologic

Clinical Trial at: Texas Oncology - Wichita Falls

Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy (MOST) (INCB-MA-MF-401)

  • Details

ClinicalTrials.gov ID: NCT02953704
Diagnosis Type: NA
USOR Number: 16092

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Wichita Falls

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

CanStem303C: A Phase III Study of BBI-608 in combination with 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients with Previously Treated Metastatic Colorectal Cancer (CRC)

  • Details

ClinicalTrials.gov ID: NCT02753127
Diagnosis Type: NA
USOR Number: 16130

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Colon Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

CanStem303C: A Phase III Study of BBI-608 in combination with 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients with Previously Treated Metastatic Colorectal Cancer (CRC)

  • Details

ClinicalTrials.gov ID: NCT02753127
Diagnosis Type: NA
USOR Number: 16130

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Denton

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Texas Oncology - Denton

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

  • Details

ClinicalTrials.gov ID: NCT03465722
Diagnosis Type: NA
USOR Number: 18016

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

SYD985.002: A multi-centre, open-label, randomized clinical trial comparing the efficacy and safety of the antibody-drug conjugate SYD985 to physician's choice in patients with HER2-positive unresectable locally advanced or metastatic breast cancer

  • Details

ClinicalTrials.gov ID: NCT03262935
Diagnosis Type: NA
USOR Number: 17027

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) (SPI-POZ-202)

  • Details

ClinicalTrials.gov ID: NCT03318939
Diagnosis Type: NSCLC
USOR Number: 17143

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

POLARIS: Palbociclib in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter Non-Interventional Study (A5481082)

  • Details

ClinicalTrials.gov ID: NCT03280303
Diagnosis Type: NA
USOR Number: 16128

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG™) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Denton

ATLAS: A Phase 2, Open-label Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinoma (CO-338-085)

  • Details

ClinicalTrials.gov ID: NCT03397394
Diagnosis Type: NA
USOR Number: 18005

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Denton

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Denton

ATLAS: A Phase 2, Open-label Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinoma (CO-338-085)

  • Details

ClinicalTrials.gov ID: NCT03397394
Diagnosis Type: NA
USOR Number: 18005

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

An International, Multi-Center, Open-Label, Randomized, Phase III Trial of Sacituzumab Govitecan versus Treatment of Physician Choice in Patients with Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Treatments (IMMU-132-05)

  • Details

ClinicalTrials.gov ID: NCT02574455
Diagnosis Type: NA
USOR Number: 16023

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Pages